These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 7540486)

  • 61. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease.
    Orbach H; Gilburd B; Brickman CM; Gerli R; Shoenfeld Y
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):892-3. PubMed ID: 12455175
    [No Abstract]   [Full Text] [Related]  

  • 62. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis.
    Genevay S; Hayem G; Verpillat P; Meyer O
    Ann Rheum Dis; 2002 Aug; 61(8):734-6. PubMed ID: 12117683
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antifilaggrin antibodies in recent-onset arthritis.
    Aho K; Palosuo T; Lukka M; Kurki P; Isomäki H; Kautiainen H; von Essen R
    Scand J Rheumatol; 1999; 28(2):113-6. PubMed ID: 10229141
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Seropositive rheumatoid arthritis in monozygotic twin sisters carrying HLA-DR4 or DR4 associated with B27.
    Tarp U; Graudal HK
    J Rheumatol; 1989 Dec; 16(12):1530-2. PubMed ID: 2625681
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Diagnostic value of the HLA phenotype in inflammatory rheumatic diseases].
    Saraux A; Guedes C; Allain J; Devauchelle V; Valls I; Baron D; Youinou P; Le Goff P
    Presse Med; 1997 Jun; 26(22):1040-4. PubMed ID: 9246112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rheumatoid factor seroconversions in relation to clinical rheumatoid arthritis.
    Aho K; Palosuo T; Niemelä N; Takala J
    Ann Clin Res; 1985; 17(1):15-8. PubMed ID: 4015026
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations.
    Campion G; Maddison PJ; Goulding N; James I; Ahern MJ; Watt I; Sansom D
    Medicine (Baltimore); 1990 Mar; 69(2):69-80. PubMed ID: 1969604
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serological abnormalities in families of patients with rheumatoid arthritis: eight to twelve years follow-up study.
    Zimmermann-Górska I; Potocka-Michajluk U; Janicka U
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):795-9. PubMed ID: 86342
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.
    Hoet RM; Boerbooms AM; Arends M; Ruiter DJ; van Venrooij WJ
    Ann Rheum Dis; 1991 Sep; 50(9):611-8. PubMed ID: 1718228
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical, laboratory, and radiographic features of rheumatoid arthritis with and without nodules.
    Saraux A; Allain J; Guedes C; Valls I; Baron D; Youinou P; Le Goff P
    Rev Rhum Engl Ed; 1997 Jan; 64(1):11-7. PubMed ID: 9051854
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The significance of immunologic tests in the diagnosis and differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis].
    Guceva B; Grlickov M; Marina N; Calovski J; Cakalaroska D; Pusevski A
    Reumatizam; 1980; 27(1):1-4. PubMed ID: 6156480
    [No Abstract]   [Full Text] [Related]  

  • 73. [Immunologic diagnosis of chronic polyarthritis].
    Müller W
    Med Klin; 1971 Apr; 66(14):499-503. PubMed ID: 4928191
    [No Abstract]   [Full Text] [Related]  

  • 74. [Rheumatoid arthritis. Requirements of a correct diagnostic determination for a more personalized therapy].
    Ferraccioli GF; Ambanelli U
    Recenti Prog Med; 1984 Oct; 75(10):883-8. PubMed ID: 6334875
    [No Abstract]   [Full Text] [Related]  

  • 75. [The rheumatoid--antinuclear factor correlation in progressive polyarthritis (author's transl)].
    Hrnŏír Z; Salavec M
    Cas Lek Cesk; 1977 Mar; 116(11):342-3. PubMed ID: 301057
    [No Abstract]   [Full Text] [Related]  

  • 76. [New pathogenetic aspects of rheumatoid arthritis].
    Abendroth K; Wessel G; Steiner G; Schütz I; Spors E
    Z Gesamte Inn Med; 1981 Sep; 36(18):653-6. PubMed ID: 6976046
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Laboratory diagnosis of rheumatoid arthritis.
    Farng E; Friedrich JB
    J Hand Surg Am; 2011 May; 36(5):926-7; quiz 928. PubMed ID: 21458927
    [No Abstract]   [Full Text] [Related]  

  • 78. The antiperinuclear factor in spondylarthropathies.
    Saraux A; de Saint Pierre V; Baron D; Valls I; Koreichi A; Youinou P; Le Goff P
    Br J Rheumatol; 1995 Oct; 34(10):912-4. PubMed ID: 7582694
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Research on the percent of positivity of the antiperinuclear factor in rheumatoid arthritis: correlation with some clinical and sere-immunological aspects].
    Damasio E; Rossi F; Viara M
    Reumatismo; 1967; 19(4):243-56. PubMed ID: 4876210
    [No Abstract]   [Full Text] [Related]  

  • 80. [Anti-keratin antibodies. A marker of progressive rheumatoid arthritis].
    Meyer O; Fabregas D; Cyna L; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):601-5. PubMed ID: 2441453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.